{"id":"W3183441818","doi":"10.1002/cncr.33809","title":"Longer term outcomes with single‐agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13‐month follow‐up from the pivotal DREAMM‐2 study","year":2021,"lang":"en","type":"article","venue":"Cancer","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Karyopharm Therapeutics; Pharmacyclics; Genentech; Celgene; Daiichi Sankyo Europe; Amgen Canada; Sanofi; GlaxoSmithKline; Spectrum Pharmaceuticals; Amgen; Bristol-Myers Squibb; Regeneron Pharmaceuticals; U.S. Department of Veterans Affairs","keywords":"Medicine; Multiple myeloma; Refractory (planetary science); Term (time); Oncology; Internal medicine; Surgery","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001409827,0.0003661951,0.000585193,0.00007814112,0.0001532657,0.00005933813,0.0001720696,0.00008738053,0.0006140948],"category_scores_gemma":[0.00024749,0.0001806094,0.0000863843,0.0003446602,0.0001101189,0.0001403514,0.0001131933,0.0003982158,0.00003246195],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006436903,"about_ca_system_score_gemma":0.0005221502,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002396869,"about_ca_topic_score_gemma":0.04196536,"domain_scores_codex":[0.9971206,0.0002136544,0.0003387141,0.0006688652,0.001094973,0.0005632341],"domain_scores_gemma":[0.99821,0.0003335697,0.0001273397,0.0007792781,0.000293556,0.0002562162],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008315724,0.003925099,0.9686713,0.0000228388,0.0009920744,0.001529729,0.002113636,0.000005900234,0.000142936,2.761657e-7,0.0003376853,0.01394281],"study_design_scores_gemma":[0.04905851,0.002023504,0.9456023,0.000304755,0.0003253412,0.000005673728,0.001664997,0.00002074332,0.0004912805,8.799288e-7,0.0002692963,0.0002326934],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996698,0.0004782548,0.000005033477,0.000286436,0.0002310177,0.001785727,0.0002120018,0.00004843045,0.0002551042],"genre_scores_gemma":[0.9957178,0.00002711497,0.0001579826,0.0002472142,0.000101538,0.0003870956,0.0002482993,0.00007349906,0.003039455],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04074278,"threshold_uncertainty_score":0.9755163,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03730700392493223,"score_gpt":0.2967258337181939,"score_spread":0.2594188297932617,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}